,102 The recent identification of “mesenchymal-like” MCC with an inflamed phenotype exhibiting better response to immunotherapy draws parallels with the SCLC-I subtype13 and contrasts “immune-cold” immunotherapy-resistant MCC with higher expression of neuroepithelial markers, including ATOH1.103. Here, ATOH1 is linked to small cell lung carcinoma.